Employment related productivity loss associated with herpes zoster and postherpetic neuralgia: a 6-month prospective study.

[1]  Patricia H. Castle,et al.  The Well-Being Assessment for Productivity: A Well-Being Approach to Presenteeism , 2011, Journal of occupational and environmental medicine.

[2]  L. Sy,et al.  Work and productivity loss related to herpes zoster , 2011, Journal of medical economics.

[3]  K. Schmader,et al.  Predictors of postherpetic neuralgia among patients with herpes zoster: a prospective study. , 2010, The journal of pain : official journal of the American Pain Society.

[4]  K. Schmader,et al.  A Prospective Study of the Herpes Zoster Severity of Illness , 2010, The Clinical journal of pain.

[5]  P. De Wals,et al.  The potential cost-effectiveness of vaccination against herpes zoster and post-herpetic neuralgia , 2008, Human vaccines.

[6]  M. Brisson,et al.  Evaluation of the cost-effectiveness in the United States of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. , 2007, Vaccine.

[7]  N. Zuithoff,et al.  Predicting postherpetic neuralgia in elderly primary care patients with herpes zoster: Prospective prognostic study , 2007, PAIN.

[8]  B. Yawn,et al.  A population-based study of the incidence and complication rates of herpes zoster before zoster vaccine introduction. , 2007, Mayo Clinic proceedings.

[9]  W. Edmunds,et al.  The burden of Herpes Zoster: a prospective population based study. , 2006, Vaccine.

[10]  R. Itzler,et al.  The incidence of herpes zoster in a United States administrative database , 2005, Journal of General Internal Medicine.

[11]  K. Schmader,et al.  Development of a measure of the burden of pain due to herpes zoster and postherpetic neuralgia for prevention trials: adaptation of the brief pain inventory. , 2004, The journal of pain : official journal of the American Pain Society.

[12]  Walter F. Stewart,et al.  Lost Productive Work Time Costs From Health Conditions in the United States: Results From the American Productivity Audit , 2003, Journal of occupational and environmental medicine.

[13]  K. Schmader.  Epidemiology and Impact on Quality of Life of Postherpetic Neuralgia and Painful Diabetic Neuropathy , 2002, The Clinical journal of pain.

[14]  W. Edmunds,et al.  Epidemiology of varicella zoster virus infection in Canada and the United Kingdom , 2001, Epidemiology and Infection.

[15]  G. Aronsson,et al.  Sick but yet at work. An empirical study of sickness presenteeism , 2000, Journal of epidemiology and community health.

[16]  G. Lenhart,et al.  Incremental 1-Year Medical Resource Utilization and Costs for Patients with Herpes Zoster from a Set of US Health Plans , 2012, PharmacoEconomics.